Trials / Recruiting
RecruitingNCT07390240
The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in Russia
The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia (HPP) in Children and Adults in Russia
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The effect of monoallelic variants in the ALPL gene on the natural course of hypophosphatasia (HPP) in children and adults in Russia (ATLANTIS)
Detailed description
Non-interventional, multi-center, cohort study for evaluation of clinical and patient reported outcomes in routine care settings
Conditions
Timeline
- Start date
- 2025-12-29
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
- First posted
- 2026-02-05
- Last updated
- 2026-04-14
Locations
4 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT07390240. Inclusion in this directory is not an endorsement.